NANOBIOTIX (NANO.PA) Stock Price, Quote, News and Overview
EPA:NANO - Euronext Paris - Matif - FR0011341205 - Common Stock - Currency: EUR
NANO.PA Quote, Performance and Key Statistics
EPA:NANO (4/25/2025, 7:00:00 PM)
2.86
-0.04 (-1.55%)
The current stock price of NANO.PA is 2.86 EUR. In the past month the price decreased by -13.6%. In the past year, price decreased by -47.52%.
NANO.PA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 17.83 | 285.16B | ||
| 1ABBV.MI | ABBVIE INC | 16.92 | 266.76B | ||
| AMG.DE | AMGEN INC | 14.07 | 131.97B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 22.33 | 112.99B | ||
| GIS.DE | GILEAD SCIENCES INC | 13.26 | 112.70B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 1657.31 | 110.78B | ||
| ARGX.BR | ARGENX SE | 352.5 | 32.72B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 24.54B | ||
| IDP.DE | BIOGEN INC | 7.16 | 15.20B | ||
| 0QF.DE | MODERNA INC | N/A | 9.45B | ||
| 1MRNA.MI | MODERNA INC | N/A | 9.08B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.54B |
Related stock screener links
About NANO.PA
Company Profile
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. The company is headquartered in Paris, Ile-De-France and currently employs 108 full-time employees. The company went IPO on 2012-10-29. The firm designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. The company develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The firm's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Company Info
NANOBIOTIX
60 rue de Wattignies
Paris ILE-DE-FRANCE FR
Employees: 110
Company Website: https://www.nanobiotix.com
Investor Relations: http://ir.nanobiotix.com
Phone: 33140260470
NANOBIOTIX / NANO.PA FAQ
What is the stock price of NANOBIOTIX today?
The current stock price of NANO.PA is 2.86 EUR. The price decreased by -1.55% in the last trading session.
What is the ticker symbol for NANOBIOTIX stock?
The exchange symbol of NANOBIOTIX is NANO and it is listed on the Euronext Paris - Matif exchange.
On which exchange is NANO.PA stock listed?
NANO.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for NANOBIOTIX stock?
11 analysts have analysed NANO.PA and the average price target is 11.24 EUR. This implies a price increase of 292.9% is expected in the next year compared to the current price of 2.86. Check the NANOBIOTIX stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NANOBIOTIX worth?
NANOBIOTIX (NANO.PA) has a market capitalization of 135.58M EUR. This makes NANO.PA a Micro Cap stock.
How many employees does NANOBIOTIX have?
NANOBIOTIX (NANO.PA) currently has 110 employees.
What are the support and resistance levels for NANOBIOTIX (NANO.PA) stock?
NANOBIOTIX (NANO.PA) has a resistance level at 3.01. Check the full technical report for a detailed analysis of NANO.PA support and resistance levels.
Is NANOBIOTIX (NANO.PA) expected to grow?
The Revenue of NANOBIOTIX (NANO.PA) is expected to decline by -3.32% in the next year. Check the estimates tab for more information on the NANO.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NANOBIOTIX (NANO.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NANO.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NANO.PA, evaluating the profitability, health, valuation and growth aspects
- NANOBIOTIX (NANO.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NANOBIOTIX (NANO.PA) Sales and EPS estimates to see what analysts future expectations are.
- NANOBIOTIX (NANO.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NANOBIOTIX (NANO.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- NANOBIOTIX (NANO.PA) Stock Chart to make your own analysis
- NANOBIOTIX (NANO.PA) Latest news and press-releases to stay up to date.
Does NANOBIOTIX (NANO.PA) stock pay dividends?
NANO.PA does not pay a dividend.
When does NANOBIOTIX (NANO.PA) report earnings?
NANOBIOTIX (NANO.PA) will report earnings on 2025-05-20.
What is the Price/Earnings (PE) ratio of NANOBIOTIX (NANO.PA)?
NANOBIOTIX (NANO.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.44).
NANO.PA Technical Analysis
NANO.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NANO.PA. NANO.PA may be in some trouble as it scores bad on both profitability and health.
NANO.PA Financial Highlights
Over the last trailing twelve months NANO.PA reported a non-GAAP Earnings per Share(EPS) of -1.44. The EPS decreased by -33.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -101.06% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NANO.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to NANO.PA. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 33.28% and a revenue growth -3.32% for NANO.PA